Gestational diabetes & diabetes in pregnancy
Neonatal birth weight percentile following the use of sensor-augmented pump therapy in women with pre-gestational diabetes
Authors' conclusion
In women with PGDM treated with an insulin pump and sensor, SAP use during pregnancy was not associated with higher neonatal birth weight percentile or the occurrences of other adverse neonatal or pregnancy outcomes.
Study context
- Population
- Women with pregestational DM treated with an insulin pump and sensor enabling SAP during pregnancy; 136 T1D, 5 T2D, 1 pancreatectomy
- Participants
- 142 women
- Exposure
- SAP use vs no SAP use during pregnancy
- SAPn = 83
- No SAPn = 59reference
- Outcome
- Neonatal birth weight percentile
Methodological detailsconsecutive women, SAP use according to physician discretion
- Consecutive women
- SAP use according to physician discretion
Main finding
As reported in the abstract
SAP
79
median
No SAP
80
median
pV = 0.96
Observational data: associations, not effects.
Further findings
Other neonatal outcomes
- Other neonatal outcomes assessed were similar
Cesarean section
- Higher rate of cesarean section in SAP; after adjusting for maternal age, BMI and history of severe hypoglycemic events, relation no longer statistically significant
Original publication
Neonatal birth weight percentile following the use of sensor-augmented pump therapy in women with pre-gestational diabetes. Diabetes Res Clin Pract. Published 24 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →